Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
laropiprant (1 trial)
niacin (1 trial)
Hypercholesterolemia (Phase 4)
Trials (1 total)
Trial APIs (2 total)